Skip to content
Home - Clinical trials - Products in Development - AZD1656    
AZD1656 Ongoing Studies

A number of clinical trials with AZD1656 Ongoing studies are currently in progress.

More studies will be added in due course. Additional AZD1656 Ongoing study information is available on ClinicalTrials.gov.

Study NumberStudy PhaseStart DateRecruitment Status
D0280C00014Phase I23 Oct 2007Active, not recruiting
A Dose-Ranging Study to Evaluate Fasting and Postprandial P-Glucose, Safety and Tolerability after oral Single, B.I.D and Q.I.D dosing of AZD6370 in Patients with Diabetes Mellitus: a Randomized, single-Blind, Placebo-Controlled, Phase I study.
D1020C00001Phase I3 Jul 2008Recruiting
A Randomized, Single-Blind, Placebo-Controlled, Single-Centre, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Interaction after Single Ascending Oral Doses of AZD1656 in Healthy Male Subjects


AstraZeneca websites
Search
Corporate Responsibility
Quick links - Products
Page tools
>
>
>
>